Barely Significant
← all excerpts

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.

Front Neurol · 2020 · PMC7067750 · PMID 32210906

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

marginally significantp = 0.07so close (0.05 < p ≤ 0.1)
(B) A marginally significant interaction between time, treatment and AD severity was observed for Factor 2, p = 0.07, and subsequent stratifications show that only mild AD subjects treated with nilvadipine had less decline compared to their placebo controls.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.